SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells
- PMID: 19901029
- PMCID: PMC2823501
- DOI: 10.1074/jbc.M109.066431
SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cells
Abstract
The scaffold attachment factors SAFB1 and SAFB2 are paralogs, which are involved in cell cycle regulation, apoptosis, differentiation, and stress response. They have been shown to function as estrogen receptor corepressors, and there is evidence for a role in breast tumorigenesis. To identify their endogenous target genes in MCF-7 breast cancer cells, we utilized a combined approach of chromatin immunoprecipitation (ChIP)-on-chip and gene expression array studies. By performing ChIP-on-chip on microarrays containing 24,000 promoters, we identified 541 SAFB1/SAFB2-binding sites in promoters of known genes, with significant enrichment on chromosomes 1 and 6. Gene expression analysis revealed that the majority of target genes were induced in the absence of SAFB1 or SAFB2 and less were repressed. Interestingly, there was no significant overlap between the genes identified by ChIP-on-chip and gene expression array analysis, suggesting regulation through regions outside the proximal promoters. In contrast to SAFB2, which shared most of its target genes with SAFB1, SAFB1 had many unique target genes, most of them involved in the regulation of the immune system. A subsequent analysis of the estrogen treatment group revealed that 12% of estrogen-regulated genes were dependent on SAFB1, with the majority being estrogen-repressed genes. These were primarily genes involved in apoptosis, such as BBC3, NEDD9, and OPG. Thus, this study confirms the primary role of SAFB1/SAFB2 as corepressors and also uncovers a previously unknown role for SAFB1 in the regulation of immune genes and in estrogen-mediated repression of genes.
Figures





Similar articles
-
Scaffold attachment factors SAFB1 and SAFB2: Innocent bystanders or critical players in breast tumorigenesis?J Cell Biochem. 2003 Nov 1;90(4):653-61. doi: 10.1002/jcb.10685. J Cell Biochem. 2003. PMID: 14587024 Review.
-
Scaffold attachment factor SAFB1 suppresses estrogen receptor alpha-mediated transcription in part via interaction with nuclear receptor corepressor.Mol Endocrinol. 2006 Feb;20(2):311-20. doi: 10.1210/me.2005-0100. Epub 2005 Sep 29. Mol Endocrinol. 2006. PMID: 16195251
-
Scaffold attachment factor B (SAFB)1 and SAFB2 cooperatively inhibit the intranuclear mobility and function of ERα.J Cell Biochem. 2012 Sep;113(9):3039-50. doi: 10.1002/jcb.24182. J Cell Biochem. 2012. PMID: 22566185
-
No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to 19p.BMC Med Genet. 2008 Dec 13;9:108. doi: 10.1186/1471-2350-9-108. BMC Med Genet. 2008. PMID: 19077293 Free PMC article.
-
SAFB1- and SAFB2-mediated transcriptional repression: relevance to cancer.Biochem Soc Trans. 2012 Aug;40(4):826-30. doi: 10.1042/BST20120030. Biochem Soc Trans. 2012. PMID: 22817742 Review.
Cited by
-
Multiomics analysis of umbilical cord hematopoietic stem cells from a multiethnic cohort of Hawaii reveals the intergenerational effect of maternal prepregnancy obesity and risks for cancers.Gigascience. 2025 Jan 6;14:giaf039. doi: 10.1093/gigascience/giaf039. Gigascience. 2025. PMID: 40388307 Free PMC article.
-
TEffectR: an R package for studying the potential effects of transposable elements on gene expression with linear regression model.PeerJ. 2019 Dec 5;7:e8192. doi: 10.7717/peerj.8192. eCollection 2019. PeerJ. 2019. PMID: 31824778 Free PMC article.
-
Scaffold association factor B (SAFB) is required for expression of prenyltransferases and RAS membrane association.Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):31914-31922. doi: 10.1073/pnas.2005712117. Epub 2020 Nov 30. Proc Natl Acad Sci U S A. 2020. PMID: 33257571 Free PMC article.
-
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer.J Clin Invest. 2022 May 2;132(9):e152383. doi: 10.1172/JCI152383. J Clin Invest. 2022. PMID: 35499080 Free PMC article.
-
Epigenetics in prostate cancer treatment.J Transl Genet Genom. 2021;5:341-356. doi: 10.20517/jtgg.2021.19. Epub 2021 Aug 27. J Transl Genet Genom. 2021. PMID: 35372800 Free PMC article.
References
-
- O'Malley B. W. (2007) Mol. Endocrinol. 21, 1009–1013 - PubMed
-
- Acevedo M. L., Lee K. C., Stender J. D., Katzenellenbogen B. S., Kraus W. L. (2004) Mol. Cell 13, 725–738 - PubMed
-
- Dobrzycka K. M., Townson S. M., Jiang S., Oesterreich S. (2003) Endocr. Relat. Cancer 10, 517–536 - PubMed
-
- Oesterreich S., Zhang Q., Hopp T., Fuqua S. A., Michaelis M., Zhao H. H., Davie J. R., Osborne C. K., Lee A. V. (2000) Mol. Endocrinol. 14, 369–381 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases